Chowdhury et al. delivered anti-CD47 antibodies by engineering E. coli to activate dendritic cells in the TME and increase the phagocytosis of cancer cells, which also promoted the cross-presentation of tumor antigens, activated infiltrating T cells, and achieved rapid tumor regression (69). The gene discussed is CD47; the disease is cancer.